Skip to content

Diagnostic value of 18F-FDG PET / CT imaging in cardiac lymphoma

18f-FDG PET/CT whole body imaging in the study of Malignant diagnosis and prognosis of cardiac lymphoma

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042905
Enrollment
Unknown
Registered
2021-01-31
Start date
2021-01-19
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac lymphoma

Interventions

Gold Standard:Pathological diagnosis

Sponsors

Beijing Anzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients with cardiac or pericardial masses found by imaging examination (ultrasound, CT, Mr, PET / CT); 2. Patients with large amount of pericardial effusion of unknown cause; 3. Those patients who can cooperate with doctors to complete PET / CT examination and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who could not tolerate PET / CT examination; 2. Women younger than 16 years old, pregnant and lactating; 3. Patients with active inflammation at the time of examination; 4. Patients with recurrence after previous cardiac tumor surgery.

Design outcomes

Primary

MeasureTime frame
tumor maximum standardized uptake value;tumor average standardized uptake value;metabolic tumor volume;total lesion glycolysis;target to backgroud ratio of the lesion;the biggest diameter of lesion;density of lesion;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactZhang Xiaoli

Beijing Anzhen Hospital Affiliated to Capital Medical University

xlzhang68@126.com+86 13370103587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026